OIE Reference Laboratory Reports Activities

Size: px

Start display at page:

Download "OIE Reference Laboratory Reports Activities"

Kenneth Brooks
6 years ago
Views:

1 OIE Reference Laboratory Reports Activities Activities in 2014 This report has been submitted : :30:20 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Bovine tuberculosis Address of laboratory: Unité des zoonoses bactériennes (ACI-ROU-009), Laboratoire de Santé Animale, Anses,14 rue Pierre et Marie Curie, Maisons-Alfort, FRANCE Tel.: +33 (0) Fax: +33 (0) address: Maria-laura.boschiroli@anses.fr Website: Name (including Title) of Head of Laboratory (Responsible Official): Dr. Pascal Boireau, Head of the Animal Health Laboratory, Anses, Maisons Alfort Name (including Title and Position) of OIE Reference Expert: Dr. María Laura Boschiroli-Cara, Research Director, head of the Tuberculosis National Reference Laboratory Which of the following defines your laboratory? Check all that apply: Governmental OIE Reference Laboratory Reports Activities,

2 ToR 1: To use, promote and disseminate diagnostic methods validated according to OIE Standards 1. Did your laboratory perform diagnostic tests for the specified disease/topic for purposes such as disease diagnosis, screening of animals for export, surveillance, etc.? (t for quality control, proficiency testing or staff training) Diagnostic Test Indicated in OIE Manual (/) Total number of test performed last year Indirect diagnostic tests Nationally Internationally IFNg test Y 40 0 Serology (cattle) N 80 0 Serology (wild boar) N 40 0 tuberculine batch control Y 14 3 Direct diagnostic tests Nationally Internationally bacteriology Y strains identification Y PCR Y spoligotyping Y MLVA Y ToR 2: To develop reference material in accordance with OIE requirements, and implement and promote the application of OIE Standards. To store and distribute to national laboratories biological reference products and any other reagents used in the diagnosis and control of the designated pathogens or disease. 2. Did your laboratory produce or supply imported standard reference reagents officially recognised by the OIE? 3. Did your laboratory supply standard reference reagents (non OIE-approved) and/or other diagnostic reagents to OIE Member Countries? 2 OIE Reference Laboratory Reports Activities, 2014

3 4. Did your laboratory produce vaccines? 5. Did your laboratory supply vaccines to OIE Member Countries? ToR 3: To develop, standardise and validate, according to OIE Standards, new procedures for diagnosis and control of the designated pathogens or diseases 6. Did your laboratory develop new diagnostic methods validated according to OIE Standards for the designated pathogen or disease? 7. Did your laboratory develop new vaccines according to OIE Standards for the designated pathogen or disease? ToR 4: To provide diagnostic testing facilities, and, where appropriate, scientific and technical advice on disease control measures to OIE Member Countries 8. Did your laboratory carry out diagnostic testing for other OIE Member Countries? 9. Did your laboratory provide expert advice in technical consultancies on the request of an OIE Member Country? Name of the OIE Member Country receiving a technical consultancy Purpose How the advice was provided IRELAND Achievement of a vaccination trial for wildlife bacteriology and PCR on samples from vaccinated badgers ToR 5: To carry out and/or coordinate scientific and technical studies in collaboration with other laboratories, centres or organisations 10. Did your laboratory participate in international scientific studies in collaboration with OIE Member Countries other than the own? OIE Reference Laboratory Reports Activities,

4 Title of the study Duration Purpose of the study Partners (Institutions) Protective efficacy of heat inactivated M. bovis as an oral vaccine against tuberculosis in European badgers 6 months Evaluation of the efficacy of an inactivated M. bovis strain in badgers for vaccination Neiker (Spain), IREC (Spain), University of Dublin (Ireland), AHVLA (UK), INRA (France), Anses (France), University College of Dublin (Ireland) ToR 6: To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases 11. Did your Laboratory collect epizootiological data relevant to international disease control? 12. Did your laboratory disseminate epizootiological data that had been processed and analysed? 13. What method of dissemination of information is most often used by your laboratory? (Indicate in the appropriate box the number by category) a) Articles published in peer-reviewed journals: 11 Biet F, Boschiroli ML n-tuberculous Mycobacterial infections of veterinary relevance Research in Veterinary Science 97:S69-S77. doi:doi: /j.rvsc Boschiroli ML, Bénet JJ Bovine tuberculosis eradication in France, p In Thoen CO, Steele JH, Kaneene JB (ed.), Zoonotic tuberculosis: Mycobacterium bovis and other pathogenic mycobacteria -Third edition. Wiley Blackwell, West Sussex, UK. Courcoul A, Moyen JL, Brugère L, Faye S, Hénault S, Gares H, Boschiroli ML Estimation of sensitivity and specificity of bacteriology, histopathology and PCR for the confirmatory diagnosis of bovine tuberculosis using latent class analysis. PloS one 9:e doi: /journal.pone Praud A, Boschiroli ML, Meyer L, Garin-Bastuji B, Dufour B Assessment of the sensitivity of the gammainterferon test and the single intradermal comparative cervical test for the diagnosis of bovine tuberculosis under field conditions. Epidemiology and infection:1-10. doi: /s Courcoul A, Moyen J-L, Brugère L, Faye S, Hénault S, Gares H, Boschiroli M-L Evaluation des caractéristiques des test de confirmation de la tuberculose bovine : Comparaison de la culture bactérienne, de l'histopathologie et de la PCR. Epidemiologie et santé animale 65: Hauer A, Cochard T, De Cruz K, Karoui C, Henault S, Biet F, Boschiroli M-L Comparaison des souches de Mycobacterium bovis isolées en Frace en élévage et dans la faune sauvage grâce aux techniques d'identification moléculaire. Epidemiologie et santé animale 65: Keck N, Moyen JL, Gueneau E, Boschiroli ML Particularités du dépistage et du diagnostic de la Tuberculose Bovine. Epidemiologie et santé animale 65:5-19. Moyen JL, Gueneau E, Keck N, Gares H, Boschiroli ML Premières évaluations de l'intérêt de la sérologie pour le diagnostic de la tuberculose bovine en France. Epidemiologie et santé animale 65: OIE Reference Laboratory Reports Activities, 2014

5 Payne A, Hars J, Fossot C, Barbier E, Hartmann A, Boschiroli ML, Gueneau E, Dufour B, Gilot-Fromont E Rôle de populations sauvages dans le système multi-hôtes de Mycobacterium bovis en Côte-d'Or: Evaluation du risque de transmission-retour aux bovins et du risque de constitution de réservoir sauvage. Epidemiologie et santé animale 65: Richomme C, Boadella M, Courcoul A, Durand B, Drapeau A, Corde Y, Hars J, Payne A, Fediaevsky A, Boschiroli ML Utilisation d'un outils sérologique pour estimer l'expositiondes sangliers à M. bovis. Epidemiologie et santé animale 65: Fediaevsky A, Courcoul A, Boschiroli ML, Reveillaud E Tuberculose bovine en France en 2013 : résultats d une stratégie plus offensive. Bulletin Epidémiologique Santé Animale-Alimentation Spécial Maladies Réglementées et Emergentes (MRE):4-11. b) International conferences: 11 De Cruz K, Karoui C, Bulach T, Hénault S, Moyen JL, Boschiroli ML n Tuberculous Mycobacteria Generating False Positive Results In TB Diagnostics in France, VI International M.bovis Conference, Cardiff, Wales. Fediaevsky A, Courcoul A, Desvaux S, Chevalier F, Jabert P, Alvado-Brette MB, Tourette I, Philizot S, Keck N, Hars J, Dufour B, Garin E, Boschiroli ML, Reveillaud E, Hendrikx P, Gueriaux D, Calavas D Strengthening Surveillance Of Bovine Tuberculosis, The Experience Learned From A Public Private Sector Initiative, The Plateforme ESA, VI International M.bovis Conference, Cardiff, Wales. Hauer A, Biet F, Boschiroli ML First genomic data of Mycobacterium bovis strains isolated from animals in France, Microbiology after the genomics revolution Genomes 2014, Paris, France. Hauer A, Cochard T, De Cruz K, Karoui C, Henault S, Biet F, Boschiroli ML Demography and Molecular Diversity Of Mycobacterium bovis Strains Isolated In France From 1978 to 2011, VI International M.bovis Conference, Cardiff, Wales. Hauer A, Cochard T, De Cruz K, Karoui C, Hénault S, Biet F, Boschiroli ML Discriminatory Power Of Spoligotyping and MLVA In French M. bovis Strains, VI International M.bovis Conference, Cardiff, Wales. Hénault S, De Cruz K, Bulach T, Karoui C, Brugère L, Gares H, Moyen JL, Gueneau E, Keck N, Courcoul A, Fediaevsky A, Boschiroli ML First line Molecular Diagnosis Of Bovine Tuberculosis: The French Experience, VI International M.bovis Conference, Cardiff, Wales. Lesellier S, Richomme C, Barrat J, Boschiroli ML, Gortazar C, Juste RA, Sevilla IA, Garrido JM, Anderson P, Dave D, Palmer S, Ni Bhuachalla D, Salguero FJ, Spiropoulos J, Sarradin P, Barc C, Pleau A, Gautier D, Pinard A, Carreras F, Adriaensen H, Lecompte F, Chambers M, Gormley E Protective Efficacy Of An Oral Heat-inactivated M. bovis Vaccine For Badgers Against Bovine Tuberculosis - A Pilot Study, VI International M.bovis Conference, Cardiff, Wales. Michelet L, De Cruz K, Bulach T, Karoui C, Hénault S, Boschiroli ML Surveillance Of Mycobacterium microti In Animals, France, , VI International M.bovis Conference, Cardiff, Wales. Moyen JL, Gueneau E, Keck N, Gares H, Boschiroli ML Use Of A Serological Test For Bovine Tuberculosis In France, VI International M.bovis Conference, Cardiff, Wales. Moyen JL, Holbert S, Boschiroli ML Adjustments and Controls In The Use Of Bovigam B1G To Improve The Reproducibility, VI International M.bovis Conference, Cardiff, Wales. Reveillaud E, Hars J, Richomme C, Boschiroli ML, Faure E, Chollet J-Y, Hendrikx P, Fediaevsky A SYLVATUB: A Bovine Tuberculosis Surveillance Network In Wildlife In France, VI International M.bovis Conference, Cardiff, Wales. c) National conferences: 4 Richomme C, Courcoul A, Durand B, Boschiroli ML Relation entre l exposition à Mycobacterium bovis chez les sangliers et la distribution des foyers de tuberculose dans les élevages bovins, Rencontres scientifiques de l'anses, Maisons-Alfort. Boschiroli ML Diagnostic et surveillance de la tuberculose bovine en France : la guerre est déclarée!, SPACE, Rennes. OIE Reference Laboratory Reports Activities,

6 Hauer A, Cochard T, De Cruz K, Karoui C, Henault S, Biet F, Boschiroli ML Molecular identification of Mycobacterium bovis strains of responsible of bovine tuberculosis outbreaks in France, in livestock and in wildlife, Journée de Doctorants de l'inra, Tours. Hauer A, Biet F, Boschiroli ML Analyse génomique des différents génotypes de Mycobacterium bovis circulants en France Journée des Doctorants de l'anses, Maisons-Alfort. d) Other: (Provide website address or link to appropriate information) 0 ToR 7: To provide scientific and technical training for personnel from OIE Member Countries To recommend the prescribed and alternative tests or vaccines as OIE Standards 14. Did your laboratory provide scientific and technical training to laboratory personnel from other OIE Member Countries? a) Technical visits: 0 b) Seminars: 0 c) Hands-on training courses: 1 d) Internships (>1 month): 0 Type of technical training provided (a, b, c or d) Country of origin of the expert(s) provided with training. participants from the corresponding country Hands-on training course Korea 1 ToR 8: To maintain a system of quality assurance, biosafety and biosecurity relevant for the pathogen and the disease concerned 15. Does your laboratory have a Quality Management System certified according to an International Standard? Quality management system adopted ISO Certificate scan (PDF, JPG, PNG format) pdf 16. Is your laboratory accredited by an international accreditation body? 17. Does your laboratory maintain a biorisk management system for the pathogen and the disease concerned? 6 OIE Reference Laboratory Reports Activities, 2014

7 (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2014, Chapter 1.1.3a) ToR 9: To organise and participate in scientific meetings on behalf of the OIE 18. Did your laboratory organise scientific meetings on behalf of the OIE? 19. Did your laboratory participate in scientific meetings on behalf of the OIE? Title of event Date (mm/yy) Location Role (speaker, presenting poster, short communications) Title of the work presented Primer encuento interamericano brucelosis y tuberculosis en el mundo animal 20/11/2014 Montpellier, France speaker TB, the French approach Comparisons amongst methodologies ToR 10: To establish and maintain a network with other OIE Reference Laboratories designated for the same pathogen or disease and organise regular inter-laboratory proficiency testing to ensure comparability of results 20. Did your laboratory exchange information with other OIE Reference Laboratories designated for the same pathogen or disease? 21. Was your laboratory involved in maintaining a network with OIE Reference Laboratories designated for the same pathogen or disease by organising or participating in proficiency tests? 22. Did your laboratory collaborate with other OIE Reference Laboratories for the same disease on scientific research projects for the diagnosis or control of the pathogen of interest? OIE Reference Laboratory Reports Activities,

8 Title of the project or contract Scope Name(s) of relevant OIE Reference Laboratories Protective efficacy of heat inactivated M. bovis as an oral vaccine against tuberculosis in European badgers control of badger disease and then spillover to cattle bovine tuberculosis OIE reference laboratory, AHVLA, GB. ToR 11: To organise inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results 23. Did your laboratory organise or participate in inter-laboratory proficiency tests with laboratories other than OIE Reference Laboratories for the same disease? te: See Interlaboratory test comparisons in: Laboratory Proficiency Testing at: see point 1.3 Purpose for inter-laboratory test comparisons 1. participating laboratories Region(s) of participating OIE Member Countries DVR-spoligotyping (organised by the bovine tuberculosis EURL) unknown (ongoing) Africa Americas Asia and Pacific Europe Middle East Biological test of tuberculins (organised by the bovine tuberculosis EURL) unknown (ongoing) Africa Americas Asia and Pacific Europe Middle East Direct extraction and microbiological culture (organised by the bovine tuberculosis EURL) unknown (ongoing) Africa Americas Asia and Pacific Europe Middle East Direct extraction and microbiological culture (organised by our laboratory) 18 Africa Americas Asia and Pacific Europe Middle East 8 OIE Reference Laboratory Reports Activities, 2014

9 ToR 12: To place expert consultants at the disposal of the OIE 24. Did your laboratory place expert consultants at the disposal of the OIE? Kind of consultancy Location Subject (facultative) OIE ad hoc group OIE Headquater revision of code chapter for animal tuberculosis 25. Additional comments regarding your report: OIE Reference Laboratory Reports Activities,

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities Activities in 2015 This report has been submitted : 2016-01-12 17:50:17 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Bovine